Where does CZ Biohub SF, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), CZ Biohub SF, LLC ranks #18,520 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does CZ Biohub SF, LLC hold?

CZ Biohub SF, LLC holds 15 US utility patents granted between 2023 and 2025, spanning 13 technology areas.

What is CZ Biohub SF, LLC's Innovation Score?

CZ Biohub SF, LLC has an Innovation Score of 52.0 out of 100 (top 11% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does CZ Biohub SF, LLC focus on?

CZ Biohub SF, LLC's top technology area is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties) with 10 patents, ranking #1,460 of 7,863 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

Is CZ Biohub SF, LLC's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for CZ Biohub SF, LLC.

What does claim depth mean for CZ Biohub SF, LLC's patents?

CZ Biohub SF, LLC's patents average 16.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the CZ Biohub SF, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

CZ Biohub SF, LLC

USPTO PatentsView assignee record - 15 granted patents across 13 technology areas, recorded in grant years 2023–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, CZ ranks #18,520 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 13 technology areas.

#18,520
of 49,997 US assignees by volume: Top 11%
by Innovation Score (52.0/100): 16.1
avg claims per patent

USPTO PatentsView assignee plate

Corpus R18520 · US Corporation #18,520 · 15 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 15 grants
MID-PACK #18,520/49,997
PHOTO-FINISH Canadian Energy…
CPC-FOCUS G01N · 13 areas
INNOV-PAR 52.0/100
CLAIMS-RICH 16.1 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2023–2025 · 3y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Canadian Energy Services L.P. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How CZ’s 52.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.6 pts (18%) Velocity 20.0 pts (38%) Breadth 12.7 pts (24%) Claim depth 9.7 pts (19%)

Qualcomm Incorporated · highest

85
CZ Biohub SF · this assignee

52
3D Lighting… · lowest

7

What this shows CZ's Innovation Score is 52.0/100 (top 11% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for CZ?

Each dot is one of CZ’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). CZ’s own 16.1 claims/patent is ABOVE the 13.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

CZ vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where CZ's grants concentrate

CZ Biohub SF, LLC is a focused PatentsView assignee: 13 CPC subclasses with 66.7% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2024 (7 grants) versus a trough of 2 in 2023. By volume, CZ sits between Connectfree Corporation and Carnegie Institution of Washington.

CZ's three-year grant acceleration

CZ Biohub SF, LLC shows 9 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Connectfree

15
Coriolis Group

15
COX Powertrain

15
Crossject

15
Canadian Energy S…

15
Canary Connect

15
Canon Europa

15
Carnegie Institut…

15
CZ Biohub SF ◀

15

What this shows CZ holds 15 patents at rank #18,485, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near CZ

By rank, the assignees closest to #18,485 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in CZ's primary technology class.

CZ's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

52 Top 11% higher than 89% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2023–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.

View data table

CZ Biohub SF, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2023	2	13.3%
2024	7	46.7%
2025partial year	6	40.0%

Which technologies does CZ Biohub SF, LLC patent most?

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 10

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 9

C07K - Peptides 6

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 6

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 4

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 4

G02B - Optical Elements, Systems OR Apparatus 3

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 1

G01J - Measurement OF Intensity, Velocity, Spectral Content, Polarisation, Phase OR Pulse Characteristics OF Infrared, Visible OR Ultraviolet LIGHT; COLORIMETRY; Radiation Pyrometry 1

H04N - Pictorial Communication, e.g. Television 1

Y02A - Technologies FOR Adaptation TO Climate Change 1

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 1

A61B - DIAGNOSIS; SURGERY; Identification 1

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

CZ Biohub SF, LLC's patent record in context - here's where to go next.

CZ Biohub SF, LLC's lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 66.7% of its portfolio - see every assignee active in that class. Explore G01N
Ranked #18,520 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare CZ Biohub SF, LLC against Connectfree Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 52.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.